Lineage Cell Therapeutics GAAP EPS of -$0.03 in-line, revenue of $1.43M misses by $0.56M

Seeking Alpha · November 12, 2026, 21:15 UTC

Topics: earnings_miss gaap_eps revenue_miss

Read the full article at Seeking Alpha

Part of the story Cerebras Systems Reports Q3 Revenue and EPS Misses Despite Strong Liquidity (3 articles)

More World news

Robinhood Reports Increase in Funded Customers Amidst Slight Decline in Platform Assets Seeking Alpha · November 12, 2026, 21:58 UTC
Imunon Sets Enrollment and Interim Analysis Timelines for OVATION-3 Clinical Trial Seeking Alpha · November 12, 2026, 22:00 UTC
Sensus Healthcare Reports Q3 Earnings Miss on Lower Revenue and Negative EPS Seeking Alpha · November 12, 2026, 22:05 UTC
Lulu's Fashion Lounge Reports Q3 2026 Revenue Decline and Lowered Full-Year Guidance Seeking Alpha · November 12, 2026, 22:05 UTC
DeFi Technologies Reports Q3 2026 Revenue of $18.3 Million and Operating Income of $7.0 Million PR Newswire · November 12, 2026, 22:05 UTC
Wolverine World Wide Raises Revenue Outlook Following Strong Q3 Growth Seeking Alpha · November 12, 2026, 22:00 UTC
Nexxen Reaffirms 2026 Guidance and Projects High Future EBITDA Margins Seeking Alpha · November 12, 2026, 22:00 UTC
Corvex Announces 6.2 MW Capacity Target for Q4 2026 and Blackwell Offtake Negotiations Seeking Alpha · November 12, 2026, 22:00 UTC
Arcos Dorados Announces Long-Term Growth Targets and $25 Million Share Buyback Seeking Alpha · November 12, 2026, 22:00 UTC
Westport Fuel Systems Reports Q3 Earnings Beat on Revenue and EPS Seeking Alpha · November 12, 2026, 22:02 UTC